1. Home
  2. Labeler Index
  3. Bioverativ Therapeutics Inc.
  4. 71104-807
  5. NDC Package Code: 71104-807-01 Eloctate

NDC Package 71104-807-01 Eloctate

Antihemophilic Factor (recombinant),Fc Fusion Protein Kit Intravenous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
71104-807-01
Package Description:
1 KIT in 1 KIT * 3 mL in 1 SYRINGE (71104-035-01) * 3 mL in 1 VIAL (71104-489-08)
Product Code:
71104-807
Proprietary Name:
Eloctate
Non-Proprietary Name:
Antihemophilic Factor (recombinant), Fc Fusion Protein
Usage Information:
This medication is used to control and prevent bleeding that happens to people (usually males) with an inherited medical condition, hemophilia A (low levels of factor VIII). It is also given before surgery to prevent too much bleeding in people with this condition. Factor VIII is a protein (clotting factor) that is in normal blood, and helps form blood clots and stop bleeding after an injury. People with low factor VIII levels may bleed longer than normal after an injury/surgery and may have bleeding inside the body (especially in the joints and muscles). This medication contains man-made factor VIII (antihemophilic factor) to temporarily replace factor VIII in the body, connected to an antibody (immunoglobulin) that helps the man-made factor VIII work longer. When used to control and prevent bleeding, this medication may help relieve pain and long-term damage caused by hemophilia A. This medication should not be used to treat von Willebrand disease.
11-Digit NDC Billing Format:
71104080701
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
  • RxCUI: 1719608 - factor VIII (b-domain deleted recombinant) FC fusion protein 1 UNT Injection
  • RxCUI: 1719608 - efmoroctocog alfa 1 UNT Injection
  • RxCUI: 1719608 - antihemophilic factor (b-domain deleted recombinant) FC fusion protein 1 UNT Injection
  • RxCUI: 1719611 - ELOCTATE 1 UNT Injection
  • RxCUI: 1719611 - efmoroctocog alfa 1 UNT Injection [Eloctate]
    • Product Type:
    Plasma Derivative
    Labeler Name:
    Bioverativ Therapeutics Inc.
    Dosage Form:
    Kit - A packaged collection of related material.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
    • Sample Package:
    No
    FDA Application Number:
    BLA125487
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    09-06-2017
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    NDC HCPCS Crosswalk

    This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

    NDC 71104-807-01 HCPCS crosswalk information with package details and bill units information.

    NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
    71104080701J7205Factor viii fc fusion recomb1 IU1111

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 71104-807-01?

    The NDC Packaged Code 71104-807-01 is assigned to a package of 1 kit in 1 kit * 3 ml in 1 syringe (71104-035-01) * 3 ml in 1 vial (71104-489-08) of Eloctate, a plasma derivative labeled by Bioverativ Therapeutics Inc.. The product's dosage form is kit and is administered via intravenous form.

    Is NDC 71104-807 included in the NDC Directory?

    Yes, Eloctate with product code 71104-807 is active and included in the NDC Directory. The product was first marketed by Bioverativ Therapeutics Inc. on September 06, 2017 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 71104-807-01?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units.

    What is the 11-digit format for NDC 71104-807-01?

    The 11-digit format is 71104080701. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-271104-807-015-4-271104-0807-01